C o g n i t i v e a n d b e h a v i o r a l i m p a i r m e n t i n m i l d hyperphenylalaninemia

As elevated phenylalanine (Phe) is detrimental to brain functions, determininga safe upper limit of blood Phe is important for initiation of treatment plansand setting Phe targets in hyperphenlalaninemic patients. It is accepted thatPhe levels below 360 μmol/L does not impair brain function and hence doesnot require treatment. Therefore, we aimed to compare cognitive functions andattention-related problems among healthy children and untreated patients withhyperphenylalaninemia (HPA). This study included 41 hyperphenylalaninemicpatients (“all HPA group”) aged 6-16 years with untreated blood Phe between240 and 600 μmol/L and 29 healthy controls. “All HPA group” was furtherdivided into 2 subgroups according to their lifetime median blood Phe levels as“Phe 360-600 μmol/L” and “Phe 240-360 μmol/L” groups. Wechsler IntelligenceScale for Children–IV (WISC-IV), Conners’ Continuous Performance Test (CPT),Strength and Difficulties Questionnaire (SDQ) and Schedule for AffectiveDisorders and Schizophrenia for School-Age Children: Present and LifetimeVersion (K-SADS-PL) were performed as a comprehensive neurocognitive,attention and behavioral assessment. The study illustrated that “all HPA”patients had significantly lower scores on all WISC-IV indexes compared tocontrols, except for Working Memory. Both “Phe 360-600 μmol/L” and “Phe240-360 μmol/L” subgroups had lower Full Scale intelligence quotient (IQ) andVerbal Comprehension scores compared to controls. “All HPA” patients alsohad longer reaction times and more peer problems than controls, indicatingattention deficits and behavioral problems. Since the results demonstratedthat children with untreated Phe levels between 240-360 μmol/L are at higherrisk for cognitive and attention-related problems, lowering the “safe” upperPhe level should be considered.

___

National Institutes of Health Consensus Development P. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics 2001; 108: 972-982.

de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ. Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 2010; 99(Suppl 1): S86-S89.

Camp KM, Parisi MA, Acosta PB, et al. Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol Genet Metab 2014; 112: 87-122.

van Spronsen FJ, van Wegberg AM, Ahring K, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 2017; 5: 743-756.

Vockley J, Andersson HC, Antshel KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 2014; 16: 188-200.

Ozalp I, Coskun T, Tokatli A, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr 2001; 43: 97-101.

Costello PM, Beasley MG, Tillotson SL, Smith I. Intelligence in mild atypical phenylketonuria. Eur J Pediatr 1994; 153: 260-263.

Weglage J, Pietsch M, Feldmann R, et al. Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res 2001; 49: 532-536.

Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, van Spronsen FJ. Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria. J Pediatr 2014; 164: 895-899.

Wechsler D. Wechsler Intelligence Scale for Children– Fourth Edition technical and interpretive manua. San Antonio, TX: Psychological Corporation; 2003.

Uluç S, Öktem F, Erden G, Gençöz T, Sezgin N. Wechsler Çocuklar İçin Zekâ Ölçeği-IV: Klinik bağlamda zekânın değerlendirilmesinde Türkiye için yeni bir dönem. Türk Psikoloji Yazıları 2011; 14: 49-57.

Conners CK, Epstein JN, Angold A, Klaric J. Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol 2003; 31: 555-562.

Conners’ Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual. North Twanda, NY: Multi-Health Systems; 2000.

Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry 1997; 38: 581-586.

Güvenir T, Özbek A, Baykara B, Arkar H, Şentürk B, İncekaş S. Güçler ve Güçlükler Anketi’nin (GGA) Türkçe uyarlamasının psikometrik özellikleri. Çocuk ve Gençlik Ruh Sağliği Dergisi 2008; 15: 65-74.

Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-988.

Gökler B, Ünal F, Pehlivantürk B, Çengel-Kültür E, Akdemir D, Taner Y. Okul çağı çocukları için duygulanım bozuklukları ve şizofreni görüşme çizelgesişimdi ve yaşam boyu şekli-Türkçe uyarlamasının geçerlik ve güvenirliği. Çocuk ve Gençlik Ruh Sağlığı Dergisi 2004; 11: 109-116.

Anderson PJ, Wood SJ, Francis DE, Coleman L, Anderson V, Boneh A. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol 2007; 32: 645-668.

Antshel KM. ADHD, learning, and academic performance in phenylketonuria. Mol Genet Metab 2010; 99 (Suppl1): S52-S58.

Azadi B, Seddigh A, Tehrani-Doost M, AlaghbandRad J, Ashrafi MR. Executive dysfunction in treated phenylketonuric patients. Eur Child Adolesc Psychiatry 2009; 18: 360-368.

Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010; 376: 1417-1427.

Stevenson M, McNaughton N. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes? Brain Res Bull 2013; 99: 63-83.

Thimm E, Schmidt LE, Heldt K, Spiekerkoetter U. Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents. J Inherit Metab Dis 2013; 36: 767-772.

van Spronsen FJ. Mild hyperphenylalaninemia: to treat or not to treat. J Inherit Metab Dis 2011; 34: 651-656.

Yildiz Y, Dursun A, Tokatli A, Coskun T, Sivri HS. Late-diagnosed phenylketonuria in an eight-year-old boy with dyslexia and attention-deficit hyperactivity disorder. Turk J Pediatr 2016; 58: 94-96.

van Spronsen FJ, Huijbregts SC, Bosch AM, Leuzzi V. Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development. Mol Genet Metab 2011; 104 (Suppl): S45-S51.

Weglage J, Ullrich K, Pietsch M, Funders B, Guttler F, Harms E. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria. Pediatr Res 1997; 42: 378-384.

Diamond A, Prevor MB, Callender G, Druin DP. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 1997; 62: i-v, 1-208.

Campistol J, Gassio R, Artuch R, Vilaseca MA, Unit PKUF-u. Neurocognitive function in mild hyperphenylalaninemia. Dev Med Child Neurol 2011; 53: 405-408.

de la Parra A, Garcia MI, Waisbren SE, Cornejo V, Raimann E. Cognitive functioning in mild hyperphenylalaninemia. Mol Genet Metab Rep 2015; 5: 72-75.

Gonzalez Garcia MB, Conde-Guzon P, Alcalde Martin C, Conde-Guzon MJ, Velasco Zuniga R. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels. Arch Argent Pediatr 2017; 115: 267-273.

Peterson E, Welsh MC. The Development of Hot and Cool Executive Functions in Childhood and Adolescence: Are We Getting Warmer? In: Goldstein S, Naglieri JA (eds). Handbook of Executive Functioning. New York, USA: Springer, 2014: 45-69.

Christ SE, Huijbregts SC, de Sonneville LM, White DA. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 2010; 99 (Suppl 1): S22-S32.

Janzen D, Nguyen M. Beyond executive function: nonexecutive cognitive abilities in individuals with PKU. Mol Genet Metab 2010; 99(Suppl 1): S47-S51.

Forbes CE, Poore JC, Krueger F, Barbey AK, Solomon J, Grafman J. The role of executive function and the dorsolateral prefrontal cortex in the expression of neuroticism and conscientiousness. Soc Neurosci 2014; 9: 139-151.

Ousdal OT, Andreassen OA, Server A, Jensen J. Increased amygdala and visual cortex activity and functional connectivity towards stimulus novelty is associated with state anxiety. PLoS One 2014; 9: e96-e146.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Clinical manifestations in trisomy 9 mosaicism

Ljiljana PEJCIC, Tatijana STANKOVIC, Ivana NIKOLIC, Marija RATKOVIC JANKOVIC, Karin VASIC

Prevalence and severity of malnutrition in pediatric neurology outpatients with respect to underlying diagnosis and comorbid nutrition and feeding related problems

Sanem YILMAZ, Sarenur GÖKBEN, Hasan TEKGÜL, Hande TEKİN, Dilek ARSLANGİRAY, Hediye REYHAN, Gül SERDAROĞLU

Posttraumatic stress disorder symptoms in children exposed to circumcision under general or local anesthesia

Betül KOZANHAN, Canan KOCAOĞLU, Metin GÜNDÜZ, Ömer Faruk AKÇA

A rare case of cephalothoracopagus janiceps conjoined twins

Dilek KURNAZ, Seda YILMAZ SEMERCİ, Tevfik GÜZELBEY, Şahin KALKAN, Merih ÇETİNKAYA

A child with idiopathic facial aseptic granuloma

Şensu TUFAN, Müzeyyen GÖNÜL, Fatma AKSOY KHURAMI, Deniz Ateş ÖZDEMİR

Aneurysmal bone cyst in the inferior nasal turbinate in a pediatric patient: A case report

Tullio IBBA, Daniela CARIOLI, Sara TORRETTA, Claudio GUASTELLA, Paola MARCHISION, Lorenzo PIGNATARO, Daniele DI PASQUALE

Evaluating the basic life support knowledge among schoolteachers: A cross-sectional survey in Kayseri, Turkey

Adem DURSUN, Serkan ÖZSOYLU, Burcu EMEKLİOĞLU, Başak Nur AKYILDIZ

Togetherness of Ebstein anomaly and giant hairy nevus in a neonate: first case in the literature

Mehmet SATAR, Nazan ÖZBARLAS, Mahmut TÜLÜCE, Ferda ÖZLÜ, Aydın YÜCEL, Banu KOZANOĞLU

Secondary hemophagocytic lymphohistiocytosis in a child with Leptospira infection: A case report

Dragana JEVTIC, Danka REDZIC, Srdjan PASIC, Miro PAREZANOVIC, Dragomir DJOKIC, Dragana ALEKSIC

A rare cause of fatal cardiac arrhythmia: Inhalation of butane gas

Hazım Alper GÜRSU, Utku PAMUK, Serhat EMEKSİZ, İlker ÇETİN, Yasemin ÖZDEMİR ŞAHAN